Evaluating Genomic Polygenic Risk Scores for Childhood Acute Lymphoblastic Leukemia in Latinos
Soyoung JeoniD, Ying Chu Lo, Libby M. MorimotoiD, Catherine MetayeriD, Xiaomei MaiD, Joseph Leo WiemelsiD, Adam J. de SmithiD, Charleston W. K. ChiangiD
Abstract
The utility of polygenic risk score (PRS) models has not been comprehensively evaluated for childhood acute lymphoblastic leukemia (ALL), the most common type of cancer in children. Previous PRS models for ALL were based on significant loci observed in genome-wide association studies (GWAS), even though genomic PRS models have been shown to improve prediction performance for a number of complex diseases. In the United States, Latino (LAT) children have the highest risk of ALL, but the transferability of PRS models to LAT children has not been studied. In this study we constructed and evaluated genomic PRS models based on either non-Latino white (NLW) GWAS or a multi-ancestry GWAS. We found that the best PRS models performed similarly between held-out NLW and LAT samples (PseudoR2 = 0.086 {+/-} 0.023 in NLW vs. 0.060 {+/-} 0.020 in LAT), and can be improved for LAT if we performed GWAS in LAT-only (PseudoR2 = 0.116 {+/-} 0.026) or multi-ancestry samples (PseudoR2 = 0.131 {+/-} 0.025). However, the best genomic models currently do not have better prediction accuracy than a conventional model using all known ALL-associated loci in the literature (PseudoR2 = 0.166 {+/-} 0.025), which includes loci from GWAS populations that we could not access to train genomic PRS models. Our results suggest that larger and more inclusive GWAS may be needed for genomic PRS to be useful for ALL. Moreover, the comparable performance between populations may suggest a more oligo-genic architecture for ALL, where some large effect loci may be shared between populations. Future PRS models that move away from the infinite causal loci assumption may further improve PRS for ALL.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 1.33
- Field percentile
- top 20%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank
Louise L. Wang, Heena Desai, … Kara N. Maxwell·Genetics in MedicinePeer-reviewed·Nov 30, 2021
- Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers
Batel Blechter, Xiaoyu Wang, … Ping Yang·JNCI Journal of the National Cancer InstitutePeer-reviewed·Sep 18, 2025
- Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome
Núria Dueñas, Hannah Klinkhammer, … Joan Brunet·Journal of Medical GeneticsPeer-reviewed·Jun 15, 2023
- Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study
Peh Joo Ho, Iain Beehuat Tan, … Jingmei Li·eLifePeer-reviewed·Mar 27, 2023
- Polygenic risk score portability for common diseases across genetically diverse populations
Sonia Moreno–Grau, Manvi Vernekar, … Carlos D. Bustamante·Human GenomicsPeer-reviewed·Sep 1, 2024
- Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes
Taishi C. Nakase, Geno Guerra, … Linda Kachuri·Neuro-OncologyPeer-reviewed·Jun 23, 2024